Academic literature on the topic 'Safety and availability'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Safety and availability.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Safety and availability"
Hanauer, Stephen B. "Balancing drug availability and patient safety." Nature Clinical Practice Gastroenterology & Hepatology 4, no. 3 (March 2007): 117. http://dx.doi.org/10.1038/ncpgasthep0762.
Full textHanauer, Stephen B. "Balancing drug availability and patient safety." Nature Clinical Practice Nephrology 3, no. 4 (April 2007): 177. http://dx.doi.org/10.1038/ncpgasthep0762x.
Full textGuarro, Sergio B. "Reliability, availability, maintainability and safety assessment." Reliability Engineering & System Safety 43, no. 3 (January 1994): 331–32. http://dx.doi.org/10.1016/0951-8320(94)90038-8.
Full textCheng, Allen C., and Ken D. Winkel. "Antivenom efficacy, safety and availability: measuring smoke." Medical Journal of Australia 180, no. 1 (January 2004): 5–6. http://dx.doi.org/10.5694/j.1326-5377.2004.tb05763.x.
Full textSimpson, Ken. "Specifying Availability/Reliability Figures for Safety Systems." Safety and Reliability 10, no. 2 (June 1990): 6–14. http://dx.doi.org/10.1080/09617353.1990.11690561.
Full textBoukef, K. "Overall strategy for blood safety and availability." ISBT Science Series 1, no. 1 (September 2006): 1–2. http://dx.doi.org/10.1111/j.1751-2824.2006.00001.x.
Full textVanderperre, E. J. "Point availability of a robot-safety device." Operations Research Letters 28, no. 3 (April 2001): 143–48. http://dx.doi.org/10.1016/s0167-6377(01)00056-6.
Full textHoussin, Remy, and Amadou Coulibaly. "Safety-based availability assessment at design stage." Computers & Industrial Engineering 70 (April 2014): 107–15. http://dx.doi.org/10.1016/j.cie.2014.01.005.
Full textMeckstroth, Steven, Michael Schwartz, and Naurang Agrawal. "NSAIDs Safety Implications of Over-the-Counter Availability." Drug Safety 7, no. 4 (1992): 241–44. http://dx.doi.org/10.2165/00002018-199207040-00001.
Full textAnasetti, Claudio, Effie W. Petersdorf, Paul J. Martin, Ann Woolfrey, and John A. Hansen. "Improving availability and safety of unrelated donor transplants." Current Opinion in Oncology 12, no. 2 (March 2000): 121–26. http://dx.doi.org/10.1097/00001622-200003000-00004.
Full textDissertations / Theses on the topic "Safety and availability"
Asanga, P. M. "Availability and safety study of an oil refinery." Thesis, University of Bradford, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.379034.
Full textWhipp, Alexander R. "Youth Farm Safety: Identification of Common Tasks and Availability of Safety and HealthTeaching Resources." The Ohio State University, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=osu152414759731944.
Full textGhafghazi, Hamidreza. "Privacy-Preserving Location-Aware Data Availability and Access Authorization in Public Safety Broadband Networks." Thesis, Université d'Ottawa / University of Ottawa, 2017. http://hdl.handle.net/10393/36006.
Full textThomaidis, Thomas Vassiliou. "Incorporation of flexibility, reliability, availability, maintenance and safety aspects in process operations and design." Thesis, University of London, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.283179.
Full textBotha, Barend HJ. "Systematic review: Availability, effectiveness and safety of assisted reproductive techniques in Sub-Saharan Africa." Master's thesis, University of Cape Town, 2018. http://hdl.handle.net/11427/29315.
Full textSevene, Esperança Júlia Pires. "Availability and safety use of drugs in vulnerable populations:the case of pregnant woman in developing countries." Doctoral thesis, Universitat de Barcelona, 2009. http://hdl.handle.net/10803/2282.
Full textThe need of a special protection to those with diminished autonomy is a common requirement to all codes. Pregnant women are defined as a vulnerable population because of the potential risk of harm of the foetus. Apart from the foetal risk, pregnant women in developing countries have additional potential for vulnerability, as in most of the cases they are economically or/and educationally disadvantaged individuals. Their generally low level of education may put them in a difficult situation to fully understand consent forms and the risk-benefit assessment provided by the researchers.
In recent years, the evidence-based medicine has been an important international goal. Mechanisms to support the use of research-based evidence in developing health policy are being promoted. The research must be sensitive to the potential for vulnerability when designing evidence-based trials and they have to assure that the vulnerable population is being protected.
With the intention to protect the vulnerable population, some groups such as pregnant women have being traditionally excluded from clinical trials. As a result of this exclusion, pregnant women are being exposed to medicines in situations where no evidence-based information is available on efficacy and safety. They are deprived of the benefits of treatment in order to be protected themselves and their offspring from an unknown risk. Although is very clear that protection of a vulnerable population, particularly the pregnant women, is mandatory in the design of any trial, the challenges of the implementation of this principle should be taken into account in order to not increase the gap between the introduction of a pharmaceutical product in the market and the availability of safety information for its use in pregnancy.
In developing countries maternal mortality is an important public health problem. Most maternal deaths occur in the poorest countries particularly in Sub-Saharan Africa. In Mozambique the rate could be between 408-1000 per 100 000 live births according to the source of information. Several studies have addressed different causes of maternal mortality in Africa, eclampsia and malaria being part of the five most reported.
There is strong evidence of the effectiveness of magnesium sulphate (MGSO4) in women with pre-eclampsia and eclampsia but the drug is not available in some countries. The example of MgSO4 has being used to describe failure in translating results of research into policy and/or practice.
For malaria treatment few drugs were considered effective and safe for use during pregnancy including chloroquine, sulphadoxine-pyrimethamine and quinine. The information on safety comes from a long experience of use. The emergency of resistance of P. falciparum to these drugs is limiting its use in most of endemic areas. The artemisinin derivatives are being strongly recommended to be used in combination with other antimalarial drugs. Preclinical studies have consistently shown that artemisinin and its derivatives are embryolethal and teratogenic in animals. Current available information is not adequate to extrapolate the results in animals to humans.
Limited data on the safety profile of antimalarial drugs during pregnancy is a challenge. Nowadays these drugs are used in pregnant women based on retrospective cumulative risk-benefit assessment. Mechanisms of prospectively monitoring the drugs use are required to protect pregnant women from the potential risk.
The aim of this thesis is to describe the (un)availability of drugs and their reasons, as well as, the (un)availability of safety information on drugs needed to be used during pregnancy in Southern Africa, and to propose mechanisms to effectively monitor drug safety in pregnancy in developing countries.
In order to achieve this objective four studies were performed. In the first study a qualitative case-study based on interviews and bibliographic review was performed in Mozambique and Zimbabwe. Factors affecting the (un)availability of MgSO4 were assessed. This study showed that research evidence regarding the effectiveness of MgSO4 for the treatment of eclampsia and pre-eclampsia, was widely known in the study countries. However, the registration, approval, acquisition and distribution of MgSO4, and hence its availability to clinicians, was affected by market and systems failures. With this study we concluded that the low cost of magnesium sulphate, as well as the mechanisms through which it is procured, means that market forces alone cannot be relied upon to ensure its availability. Governments and international organizations must be prepared to intervene to ensure the wide availability of low cost, effective drugs critical to improving public health in Africa.
The second and the third studies shown that antimalarial drugs are being used in pregnant women even without information on its safety profile in this particular group. Robust safety monitoring systems are clearly needed in developing countries to accompany the deployment of new drugs, especially those with a potential teratogenic risk.
The fourth study showed that spontaneous reporting system may be a tool for drug safety monitoring. This system could be used to increase health care providers' and patients' awareness of possible ADRs, and to develop a culture to report these reactions. Spontaneous reporting and pregnancy registries were presented as examples of mechanisms that could and should be in place.
Recommendations on how these systems could be effectively implemented in resource constrained countries were also presented.
All these studies suggest that the definition of vulnerability of pregnant women in developing countries should not be restricted to the potential risk of harm of the foetus (harm-based definition) or to the difficulty of fully understanding consent forms (consent-based definitions). Women are also vulnerable because of the high risk of dying from any cause related to or aggravated by the pregnancy. The implementation of these ethic principles need to take into account the urgent need to implement effective and safe drugs targeted to reduce the burden of maternal morbidity and mortality.
La investigación relativa a los seres humanos debe realizarse dentro de unos estándares que promuevan la protección de sus derechos. Varios códigos han sido desarrollados y todos ellos coinciden unánimemente en los siguientes principios éticos: el respeto por las personas, la beneficencia y la justicia. La realización de estos principios debe asegurar la dignidad, los derechos, la seguridad y el bienestar de los participantes en una investigación biomédica sean preservados.
La necesidad de una protección especial hacia aquellos seres cuya autonomía sea limitada es un requerimiento común para todos los códigos. Las mujeres embarazadas están definidas como un grupo de población vulnerable dado el riesgo potencial de causar daño al feto. Además del riesgo para el feto, las mujeres embarazadas en los países en desarrollo son potencialmente más vulnerables, y suelen contar con desventajas a nivel económico y/o educativo. Su nivel de educación, por lo general bajo, les pone en una situación difícil, dificultando la comprensión de los formularios de consentimiento y la evaluación del riesgo-beneficio que prestan los investigadores.
En los últimos años, la medicina basada en la evidencia ha sido una meta muy importante a nivel internacional. Se están promoviendo mecanismos para respaldar el uso de la evidencia científica para la definición de política de desarrollo de la salud. La investigación debe ser sensible a la vulnerabilidad potencial cuando se diseñan ensayos basados en la evidencia. Además, se debe asegurar que la población vulnerable esté siendo protegida.
Con la intención de proteger a esa población vulnerable, algunos grupos como los de mujeres embarazadas han sido tradicionalmente excluidos de los ensayos clínicos. Como resultado de esta exención, algunas mujeres embarazadas están siendo expuestas a medicamentos de los que no hay información basada en la evidencia en cuanto a su eficacia y seguridad. Este hecho las priva de los beneficios del tratamiento que debería protegerlas, a ellas y sus hijos, de un riesgo desconocido. Aunque está muy claro que proteger a una población vulnerable, particularmente a las mujeres embarazadas, es obligatorio en el diseño de un ensayo clínico, los retos de la implementación de este principio no deberían aumentar el vacío entre la introducción de un producto farmacéutico en el mercado y la disponibilidad de información sobre su seguridad para uso en el embarazo.
En los países en vías de desarrollo la mortalidad materna es un problema importante de salud pública. La mayoría de muertes maternas ocurren en los países más pobres, particularmente en África Subsahariana. En Mozambique el índice puede ser entre 408-1000 por 100000 nacidos vivos, dependiendo de la fuente de información. Diferentes estudios han señalado diversas causas de mortalidad materna en África, encontrándose la eclampsia y la malaria entre las cinco primeras.
Existe una gran evidencia de la eficacia del sulfato de magnesio (MGSO4) en mujeres con pre-eclampsia y eclampsia, sin embargo el fármaco no está disponible en algunos países. El ejemplo del sulfato de magnesio se ha utilizado para describir el fracaso en el traslado de los resultados de la investigación a la práctica y/o política.
Para el tratamiento de la malaria, se consideró seguro el uso durante el embarazo de algunos fármacos incluyendo cloroquina, sulfadoxinapirimetamina y quinina. La información sobre seguridad responde a una gran experiencia de uso. El aumento de resistencia de P. falciparum a estos fármacos está limitando su uso en la mayoría de las zonas endémicas. Actualmente se está recomendando el uso de los derivados de la artemisinina en combinación con otros fármacos antimaláricos. Los estudios preclínicos han mostrado sistemáticamente que la artemisina y sus derivados son embrioletales y teratogénicos en animales. La información disponible hasta la fecha no es adecuada para extrapolar los resultados de los animales a los humanos.
Los datos limitados en el perfil de seguridad de los fármacos antimaláricos durante el embarazo constituyen un desafío. Hoy en día, estos fármacos se usan en mujeres embarazadas basándose en una valoración retrospectiva acumulativa de riesgo-beneficio. Se necesitarían mecanismos de monitorización prospectiva del uso de los fármacos para proteger a las mujeres de su riesgo potencial.
El objetivo de esta tesis es el de describir la disponibilidad o no disponibilidad de los fármacos y sus razones; describir la disponibilidad o no disponibilidad de información sobre la seguridad de estos fármacos que son de uso necesario en el sureste de África. Se pretende también proponer mecanismos efectivos para monitorizar la seguridad de los fármacos en el embarazo en los países en desarrollo.
Para alcanzar estos objetivos se llevaron a cabo cuatro estudios. El primero consistía en un estudio cualitativo de casos basados en entrevistas y en una revisión bibliográfica en Mozambique y Zimbawe. Se evaluaron los factores que afectaban a la disponibilidad o no disponibilidad del sulfato de magnesio. El estudio mostró que la evidencia científica respecto a la eficacia del sulfato de magnesio para el tratamiento de la eclampsia y la pre-eclampsia fue ampliamente conocida en los países del estudio. Sin embargo, el registro, aprobación, adquisición y distribución del sulfato de magnesio y como consecuencia, su disponibilidad para los médicos se vio afectada por fallos de mercado y de sistema. Este estudio concluye que el bajo coste del sulfato de magnesio, así como el mecanismo a través del cual se obtiene, significa que las fuerzas del mercado por si solas no pueden asegurar su disponibilidad. Los gobiernos y las organizaciones internacionales deben estar preparados para intervenir y para asegurar una amplia disponibilidad de fármacos efectivos de bajo coste, críticos para mejorar la salud pública en África.
El segundo y tercer estudio mostraron que los fármacos antimaláricos se están usando en mujeres embarazadas sin contar con información sobre su perfil de seguridad en este grupo particular. Se necesita claramente una monitorización fuerte y segura en los países en vías de desarrollo para acompañar el despliegue de los nuevos fármacos, especialmente aquellos que conllevan un potencial riesgo teratogénico.
El cuarto estudio mostró que el sistema de notificación espontánea puede ser una herramienta para la monitorización de la seguridad de los fármacos. Este sistema se podrá usar para incrementar la consciencia en proveedores de salud y en enfermos sobre las posibles reacciones adversas de fármacos. Ello permitirá desarrollar una cultura de notificación de estas reacciones. La notificación espontánea y los registros de embarazo se presentaron como ejemplos de mecanismos que podrían y deberían ser implementados. Las recomendaciones de cómo estos sistemas podrían ser implementados de forma efectiva en países con recursos limitados también fueron presentadas.
Todos estos estudios sugieren que la definición de vulnerabilidad de las mujeres embarazas en los países en desarrollo no se puede restringir a causa del riesgo potencial de daño al feto, o debido a la dificultad de entender por completo los formularios de consentimiento. También son vulnerables por el riesgo elevado de morir por alguna causa relacionada o agravada por el embarazo. La implementación de estos principios éticos necesita tener en cuenta la necesidad de implementar fármacos diana efectivos y seguros para reducir la mortalidad y morbilidad materna.
Olivier, Anna-Louise. "Psychological conditions that mediate between job demands and resources, and work engagement / Anna-Louise Olivier." Thesis, North-West University, 2006. http://hdl.handle.net/10394/1401.
Full textKarimi, Hossein. "QUANTITATIVE ANALYSIS OF THE IMPACT OF CRAFT LABOR AVAILABILITY ON CONSTRUCTION PROJECT PERFORMANCE." UKnowledge, 2017. http://uknowledge.uky.edu/ce_etds/56.
Full textMeng, Huixing. "Modeling Patterns for Performance Analysis of Production and Safety Systems in Process Industry." Thesis, Université Paris-Saclay (ComUE), 2017. http://www.theses.fr/2017SACLX074/document.
Full textProduction and safety systems are crucial in the process industry. Their performances affect significantly the industry interests. These systems have common behaviors. Such behaviors can be captured in models via modeling patterns. By reusing modeling patterns, the modeling process can be simplified and made more efficient.In this thesis, we propose a versatile set of modeling patterns. They are classified according to their purpose, which reflects what a modeling pattern works for. Modeling patterns are exhibited as a catalog. Based on reviewing numerous production and safety systems, twenty-four (24) modeling patterns are introduced. Each pattern is illustrated with a set of structured items. We propose a pattern-based methodology for performance analysis of production and safety systems.To test the applicability of proposed modeling patterns, we conducted experimental studies on a set of production and safety systems. All systems are extracted from the literature. These systems are declared to cover most of modeling difficulties. Comparisons are performed between the results obtained using modeling patterns and those reported in the literature
Basharat, Salma. "Proactive Emergency Preparedness in the Barents Sea." Thesis, Norges teknisk-naturvitenskapelige universitet, Institutt for produksjons- og kvalitetsteknikk, 2012. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-18401.
Full textBooks on the topic "Safety and availability"
Reliability, availability, maintainability, and safety assessment. Chichester: J. Wiley, 1992.
Find full textVillemeur, Alain. Reliability, availability, maintainability and safety assessment. Chichester: John Wiley and Sons, 1992.
Find full textFEDERAL AVIATION ADMINISTRATION. Takeoff safety training aid announcement of availability. Washington, D.C. (800 Independence Ave., S.W., Washington 20591): U.S. Dept. of Transportation, Federal Aviation Administration, 1994.
Find full textKumar, Uday, Alireza Ahmadi, Ajit Kumar Verma, and Prabhakar Varde, eds. Current Trends in Reliability, Availability, Maintainability and Safety. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-23597-4.
Full textCosper, Donna K. Availability of passenger safety information for improved survival in aircraft accidents. Washington, D.C: U.S. Department of Transportation, Federal Aviation Administration, Office of Aerospace Medicine, 2004.
Find full textUnited States. National Aeronautics and Space Administration., ed. Electronic availability of microgravity experiments safety and integration requirements documents. [Washington, D.C.]: National Aeronautics and Space Administration, 1995.
Find full textservice), SpringerLink (Online, ed. Handbook of Reliability, Availability, Maintainability and Safety in Engineering Design. London: Springer London, 2009.
Find full textSchneeweiss, Winfrid G. Reliability modeling: (modeling in the fields of dependability, availability, maintainability, and safety engineering). Hagen: LiLoLe-Verlag, 2001.
Find full textAviation safety: Enhanced oversight and improved availability of risk-based data could further improve safety : report to congressional committees. Washington, D.C.]: U.S. Govt. Accountability Office, 2011.
Find full textFaulin, Javier. Simulation Methods for Reliability and Availability of Complex Systems. London: Springer-Verlag London, 2010.
Find full textBook chapters on the topic "Safety and availability"
Aggarwal, K. K. "Maintainability and Availability." In Topics in Safety, Reliability and Quality, 153–77. Dordrecht: Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-1928-3_8.
Full textBaro, Sylvain. "A High-Availability Safety Computer." In Security of Computer Architectures, 425–46. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118600696.ch11.
Full textLydersen, Stian. "Periodically Overhauled Systems Availability." In Probabilistic Safety Assessment and Management ’96, 172–77. London: Springer London, 1996. http://dx.doi.org/10.1007/978-1-4471-3409-1_28.
Full text(Ravi) Ravishankar, T. J., Lionel D. Bates, and John M. Romagnino. "Setpoint Design Impact on Availability." In Probabilistic Safety Assessment and Management, 3678–84. London: Springer London, 2004. http://dx.doi.org/10.1007/978-0-85729-410-4_588.
Full textRedmill, F., and K. Boot-Handford. "Another Dimension of Availability." In Achieving Safety and Reliability with Computer Systems, 276–84. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3461-0_23.
Full textRoth, Dana L. "CHAPTER 7. Commercial Availability, Safety, and Hazards." In Chemical Information for Chemists, 184–205. Cambridge: Royal Society of Chemistry, 2014. http://dx.doi.org/10.1039/9781782620655-00184.
Full textTimpanaro, Juan Pablo, Isabelle Chrisment, and Olivier Festor. "Improving Content Availability in the I2P Anonymous File-Sharing Environment." In Cyberspace Safety and Security, 77–92. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-35362-8_8.
Full textZio, E., M. Marella, and L. Podofillini. "Availability Assessment of Multi-State Systems with Operational Dependence." In Probabilistic Safety Assessment and Management, 914–19. London: Springer London, 2004. http://dx.doi.org/10.1007/978-0-85729-410-4_148.
Full textSignoret, Jean-Pierre, and Alain Leroy. "Extensions to Production Availability and Functional Safety Analyses." In Springer Series in Reliability Engineering, 121–36. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-64708-7_6.
Full textMorant, Amparo, Anna Gustafson, and Peter Söderholm. "Safety and Availability Evaluation of Railway Signalling Systems." In Lecture Notes in Mechanical Engineering, 303–16. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-23597-4_22.
Full textConference papers on the topic "Safety and availability"
Wang, Peng, and Yan Bai. "Safety and availability optimization of safety instrumented system." In 2011 9th International Conference on Reliability, Maintainability and Safety (ICRMS 2011). IEEE, 2011. http://dx.doi.org/10.1109/icrms.2011.5979330.
Full textCossy, Melanie. "Software Safety Architecture to Fulfill Increased Safety and Availability Requirements." In SAE 2003 World Congress & Exhibition. 400 Commonwealth Drive, Warrendale, PA, United States: SAE International, 2003. http://dx.doi.org/10.4271/2003-01-0102.
Full textCarlucci, Elisa, and Leonardo Tognarelli. "e-LNG Plant Availability Estimation." In Proceedings of the 29th European Safety and Reliability Conference (ESREL). Singapore: Research Publishing Services, 2019. http://dx.doi.org/10.3850/978-981-11-2724-3_0733-cd.
Full textHun, Kok Ping, and Khairul Nizam Baharim. "Predictive Modelling for Asset Availability using Artificial Intelligence." In 33rd European Safety and Reliability Conference. Singapore: Research Publishing Services, 2023. http://dx.doi.org/10.3850/978-981-18-8071-1_p050-cd.
Full textZheng, Heng, and Liming Ren. "Availability analysis of satellite constellation." In 2009 8th International Conference on Reliability, Maintainability and Safety (ICRMS 2009). IEEE, 2009. http://dx.doi.org/10.1109/icrms.2009.5270198.
Full textSalmi, Louis-Rachid, Eric Tellier, and Bruno Simonnet. "PW 2149 Issues in data availability and results in two international surveys on drowning." In Safety 2018 abstracts. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/injuryprevention-2018-safety.437.
Full textSackx, Eva, and Antonio Longhi. "An Integrated Reliability, Availability, and Maintainability Approach for Metro Systems." In 33rd European Safety and Reliability Conference. Singapore: Research Publishing Services, 2023. http://dx.doi.org/10.3850/978-981-18-8071-1_p541-cd.
Full textAkrouche, Joanna, Mohamed Sallak, Eric Châktelet, Fahed Abdallah, and Hiba Haj Chhadâ. "Methodology for Imprecise Availability Computing and Optimization." In Proceedings of the 29th European Safety and Reliability Conference (ESREL). Singapore: Research Publishing Services, 2019. http://dx.doi.org/10.3850/978-981-11-2724-3_0599-cd.
Full textZhao, Guangyan, Yufeng Sun, Weiwei Hu, and Tong Qin. "Study on constellation per-slot availability." In 2013 International Conference on Quality, Reliability, Risk, Maintenance, and Safety Engineering (QR2MSE). IEEE, 2013. http://dx.doi.org/10.1109/qr2mse.2013.6625582.
Full textBrunink, Marc, Martin Susskraut, and Christof Fetzer. "Boundless memory allocations for memory safety and high availability." In Networks (DSN). IEEE, 2011. http://dx.doi.org/10.1109/dsn.2011.5958203.
Full textReports on the topic "Safety and availability"
Agency, Food Standards. The impact of labour shortages on UK food availability and safety. Food Standards Agency, November 2023. http://dx.doi.org/10.46756/sci.fsa.oac747.
Full textHuysamen, Kirsten, Murray Collins, and Alice Wardle. MIS070 GSR Technical study to to assess and develop performance requirements and test protocols for driver availability monitoring systems. TRL, December 2021. http://dx.doi.org/10.58446/tmfa9969.
Full textCook, Stephen, and Loyd Hook. Developmental Pillars of Increased Autonomy for Aircraft Systems. ASTM International, January 2020. http://dx.doi.org/10.1520/tr2-eb.
Full textSrivastava, Shilpi, Jeremy Allouche, Roz Price, and Tina Nelis. Bringing WASH into the Water–Energy–Food Nexus in Humanitarian Settings. Institute of Development Studies (IDS), February 2022. http://dx.doi.org/10.19088/ids.2022.006.
Full textWiley, Jenny L., Camille K. Gourdet, and Brian F. Thomas. Cannabidiol: Science, Marketing, and Legal Perspectives. RTI Press, April 2020. http://dx.doi.org/10.3768/rtipress.2020.op.0065.2004.
Full textHedrick and Jacobs. PR-457-14201-R01 Variable Natural Gas - Composition Effects and Control Methods for Two-Stroke Engines. Chantilly, Virginia: Pipeline Research Council International, Inc. (PRCI), June 2015. http://dx.doi.org/10.55274/r0010027.
Full textZandiatashbar, Ahoura, Jochen Albrecht, and Hilary Nixon. A Bike System for All in Silicon Valley: Equity Assessment of Bike Infrastructure in San José, CA. Mineta Transportation Institute, October 2023. http://dx.doi.org/10.31979/mti.2023.2162.
Full textLuo, Hao, Ricardo Chahine, Arianna Rambaram, Elizabeth Theresa Rosenzweig, Konstantina Gkritza, and Hua Cai. Assessing the Travel Demand and Mobility Impacts of Transformative Transportation Technologies in Indiana. Purdue University, 2023. http://dx.doi.org/10.5703/1288284317374.
Full textToloo, Sam, Ruvini Hettiarachchi, David Lim, and Katie Wilson. Reducing Emergency Department demand through expanded primary healthcare practice: Full report of the research and findings. Queensland University of Technology, January 2022. http://dx.doi.org/10.5204/rep.eprints.227473.
Full textYoozbashizadeh, Mahdi, and Forouzan Golshani. Robotic Parking Technology for Congestion Mitigation and Air Quality Control Around Park & Rides. Mineta Transportation Institute, June 2021. http://dx.doi.org/10.31979/mti.2021.1936.
Full text